Objectives: The purpose of this paper is to review the literature since 1970 documenting the
effects of antipsychotic agents on serum lipids, including a discussion of possible …

This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …

OBJECTIVE: The association of hyperglycemia and hypercholesterolemia with use of
atypical antipsychotics has been documented in case reports and uncontrolled studies. The …

Excessive body weight gain (BWG) is a common side effect of some typical and atypical
antipsychotic drugs (APs). Convergent evidence suggests a hierarchy in the magnitude of …

Background: Weight gain is a common adverse effect associated with the use of most
antipsychotic drugs. Leptin has been reported to be associated with antipsychotic-induced …

BACKGROUND: Many adverse effects of atypical antipsychotic treatment are associated
with antagonism of monoamine receptors; however, data indicate that important metabolic …

Atypical antipsychotics have been linked to weight gain, hyperglycemia, and diabetes. We
examined the effects of atypical antipsychotics olanzapine (OLZ) and risperidone (RIS) …

Background: The onset of diabetes and impaired glucose metabolism among schizophrenic
patients has been the topic of numerous recently published articles, with research …

Weight gain is a frequent and important side effect of psychopharmacotherapy. Recent
studies suggest that the fat-cell-derived hormone leptin and the tumor necrosis factor-α (TNF …

Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …